Home

Michael W Kosloske

CIK 1569146 · Chief of Product Innovation · last filed 2025-12-11

Michael W Kosloske is a Chief of Product Innovation who has filed 9 SEC Form 4 insider transactions across 2 companies since 2013. The most recent filing, for OTH, was dated Dec 11, 2025. Across all open-market trades the lifetime net is −$26.7M, making them a net seller over the disclosed history. 32 SEC filings were submitted jointly with Health Plan Intermediaires, LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

9

Lifetime Open-Market Net

-$26.72M

Filer Profile

Reported Address
C/O HEALTH INSURANCE INNOVATIONS, INC.
15438 N. FLORIDA AVENUE, SUITE 201
TAMPA, FL 33613
Related Filers
Health Plan Intermediaires, LLC — 32 joint filings, latest 2020-02-19
Health Plan Intermediaries Sub, LLC — 32 joint filings, latest 2020-02-19
Lori Kosloske — 20 joint filings, latest 2018-06-11
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NextBoat Inc. (OTH) Delisted Director — $2.57 — $0 1 2025-12-11
Benefytt Technologies, Inc. (HIIQ) Delisted Chief of Product Innovation 5,963 — — -$26.72M 8 2020-02-06

Recent Filings

9 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-12-11 NextBoat Inc. (OTH) Delisted Grant (A) — $0 EDGAR
2020-02-06 Benefytt Technologies, Inc. (HIIQ) Delisted Sell (S) −600,000 -$14.43M EDGAR
2019-07-03 Benefytt Technologies, Inc. (HIIQ) Delisted Mixed −153,480 -$4.04M EDGAR
2019-06-26 Benefytt Technologies, Inc. (HIIQ) Delisted Sell (S) −316,203 -$8.25M EDGAR
2019-04-24 Benefytt Technologies, Inc. (HIIQ) Delisted Mixed +114,669 -$191.1K EDGAR
2017-11-20 Benefytt Technologies, Inc. (HIIQ) Delisted Grant (A) — $0 EDGAR
2016-03-10 Benefytt Technologies, Inc. (HIIQ) Delisted Tax (F) −2,132 -$13.1K EDGAR
2013-12-11 Benefytt Technologies, Inc. (HIIQ) Delisted Mixed +387,420 -$2.40M EDGAR
2013-03-12 Benefytt Technologies, Inc. (HIIQ) Delisted Sell (S) — $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.